Bilcare Ltd. is a holding company, which engages in the provision of pharma packaging research solutions. It includes pharmaceutical packaging, global clinical services, reasearch and development services and anti counterfeit technology. The company was founded by Mohan Harakechand Bhandari on July 1, 1987 and is headquartered in Pune, India.

Bilcare Limited

Bilcare is involved in pharmaceutical packaging innovation, focusing on packaging solutions that enhance patient care.

Bilcare

Bilcare Career

Bilcare Research | 8,325 followers on LinkedIn. Shaping Pharma Brands, Caring for Patients | Bilcare is market leader in pharma packaging, packaging innovation and research that partners with the pharmaceutical industry to improve patient health-care outcomes. We endeavor to deliver effective and affordable solutions that enhance the speed and quality of drug discovery and help build and protect brands by ensuring the delivery of genuine medicines to patients.

Bilcare PPI offers Innovative Pharmaceutical Packaging Solutions comprising of a wide range of specialty Polymer Films and Aluminum Foils mainly used for packaging of solid dosage pharmaceutical products.

Head -Research Services at Bilcare Singapore Pte. Limited

Sunil Satav

Vice President - QA & Technical Services at Bilcare Research - Singapore & India

Shreedhar Tantri

Manager at Bilcare Limited

Hrishikesh Rajwade

Vice President Exports -Europe & USA

Vishal Shah

Bilcare Research

What an incredible experience at CPHI Milano 2024! Over the past two days, we’ve been truly inspired by the overwhelming support, interest, and enthusiasm from customers and partners from all around the world. It’s exciting to see how Bilcare’s cutting-edge products, comprehensive technical services, and our relentless drive for innovation continue to resonate globally. At Bilcare Research GmbH, we now ensure delivery within days, demonstrating our commitment to speed and reliability. As a trusted partner, we remain at the forefront of driving innovation in the pharma industry. Our longstanding dedication to Shaping Pharma Brands and Enabling Patient Care is reflected in our user-centered design approach, where patient needs are always prioritized. A big thank you to CPHI Worldwide for providing yet another excellent platform that brings the industry together. Your continued service over the years has been exceptional. #CPHI2024 #PharmaInnovation #PatientCare #BilcareResearch #ShapingPharma #GlobalPharma #InnovationInHealthcare #TrustedPartner #PharmaceuticalIndustry #CPHIWorldwide

🌟 Pioneering Pharma Packaging Innovation with Bilcare Research 🌟 At Bilcare Research, we are redefining the landscape of pharmaceutical packaging with an unwavering commitment to innovation and excellence. Our approach goes beyond the conventional, integrating cutting-edge design, user convenience, and robust product protection to ensure patient safety and compliance. 💡 Design that Speaks for Itself Our packaging solutions are not just about enclosing a product—they are about creating a seamless experience for the end-user. Whether it's child-resistant blister packs or senior-friendly opening mechanisms, we prioritize designs that enhance usability and accessibility. We believe that good design should not only protect but also empower users. 🔬 Driving Product Innovation Innovation is at the heart of what we do. From smart packaging solutions that integrate digital technologies for better patient adherence to eco-friendly materials that reduce environmental impact, we are continuously pushing the boundaries of what’s possible in pharmaceutical packaging. Our goal is to create solutions that not only meet but exceed industry standards. 📈 Raising the Bar in the Pharma Industry The pharmaceutical industry is evolving rapidly, and with it, the need for innovative packaging solutions that address new challenges. At Bilcare, we are proud to be at the forefront of this evolution, developing products that offer superior protection against counterfeiting, moisture, and light, thus ensuring the integrity of life-saving medications. Our research-driven approach enables us to anticipate industry trends and proactively develop solutions that keep our partners ahead of the curve. 🌍 Sustainability Matters We are deeply committed to sustainability. Our focus on reducing carbon footprint and minimizing waste is reflected in our product development. We leverage advanced materials and manufacturing processes to create packaging that is as eco-friendly as it is effective. At Bilcare, we believe that innovation and sustainability go hand in hand. As we continue to push the boundaries of pharmaceutical packaging, we invite you to join us on this journey of innovation, excellence, and impact. Together, we can transform the way the world views pharma packaging—making it safer, smarter, and more sustainable. #PharmaPackaging #PharmaceuticalInnovation #BilcareResearch #PackagingDesign #PatientSafety #Sustainability #HealthcareInnovation #PharmaIndustry #PharmaPackagingSolutions #InnovationInPharma

Bilcare Research GmbH @ CPHI Milan, We are launching a...🤫 A Radically New Blister Pack System! 🔹 Blister solutions that are Easy to Recycle ♻ 🔹 Reduce packaging Size & Material 📦 🔹 Improves Moisture Barrier over 3X 💊 🔹 Vinyl-free packaging for Dioxin-free Air 🌍 Meet us to know more about the New Dimensions of Pharma Packaging All Bilcare Materials undergo rigorous technical & quality testing, and are filed with notable industry bodies like the USFDA DMFs. For more, feel free to reach us at global@bilcare.com #pharmapackaging #packaginginnovation #sustainablesolutions

A wonderful Day 1 — Bilcare Research @ Pharmapack Europe Paris! Bilcare Research is a trusted partner for High Barrier solid dosage Packaging for Pharmaceuticals. With innovative patient-centred solutions, as well as moving towards environmentally aware packaging, Bilcare Research is poised to lead the Pharma Packaging industry and the greater Pharmaceutical Industry to meaningfully support defining the future of packaging innovation 👏👏 #primarypackaging #blisterpackaging #blisterlidding #lidfoils #pharmapackaging #pharmaceuticalindustry #pharmapackaging Suhas Nemmaniwar Somenath Mukherjee Ruchi Bhandari Vishal Shah Esperia Tsangaropoulou

Bilcare Research @ Pharmapack Europe Paris We are ready to meet !! We are at K-53. Looking forward to the next few days of engagement and interaction with our esteemed Global Customers !! Learn about our Halogen-Free Packaging for Pharma, in addition to a full range of Pharma Packaging Innovation Products, Technical Services and Global Reach 🌏 Somenath Mukherjee Vishal Shah Suhas Nemmaniwar Esperia Tsangaropoulou Ruchi Bhandari #pharmapackaging #pharmaceuticalindustry #pharma #primarypackaging #blisterpackaging

Bilcare Group, an industry leader in Pharma Packaging Innovations, is proud to announce it is conferred with the Abbott Strategic Business Partner 2023 award 👏👏👏 A testament to Bilcare's innovative approach & dedication in providing unique solutions in shaping Pharma Brands and caring for end Consumers. Thank you Abbott for the recognition 🙌 #pharmapackaging #abbott #pharmaindustry #packagingsolutions #pharmaceuticalmanufacturing

Rediscover Bilcare Research - Meet us @ Pharmapack Europe Set a meeting! https://lnkd.in/e2dBjrr2

User-Centred Design Challenge : Can pharma packaging be Secure & Easy to use at the same time? 🤔 Bilcare Research pioneered User-Centred Packaging for Pharmaceuticals. Using its 5-C Framework, Bilcare has developed a range of CRSF (Child Resistant Senior Friendly) Packages that ensure seamless patient-convenient packaging designed for Child Resistance. Explore Bilcare Research Crispack - Peel, Push and Peel&Push solutions. 💊💊 #packagingdesign #pharmacology #barrierpackaging #childprotection #ideo

Bilcare Research is known around the world for only the best-in-class Pharma Packaging materials supplies & stalwart customer service, regardless of the time zone. A One-Stop-Shop for all Pharma Solid Dosage Packaging, Bilcare shapes Pharma brands with focus on patient care, via novel Packaging solutions. Discover Bilcare Pharma Packaging Innovations : https://lnkd.in/ejmXUY-w

A highly successful show at CPHI India 2023 ! Tremendous quantum sharing of knowledge, opportunities and energies between Bilcare Pharma Packaging Innovations and Customers & Partners all across the Asia Pacific. A huge thanks to all our valued Customers for spending time with us. Thank you team Bilcare for being on top of your game! 👏👏 #packaginginnovation #patientfirst #brandgrowth #sustainablesolutions

	Mar '21	Jun '21	Sep '21	Dec '21	Mar '22	Jun '22	Sep '22	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	Mar '24	Jun '24
net income	117M -	-152.80M 230.60%	224M 246.60%	-139M 162.05%	-58.40M 57.99%	-66.90M 14.55%	-56.90M 14.95%	-187.80M 230.05%	462.06M 346.04%	-79.10M 117.12%	-75.90M 4.05%	-68.50M 9.75%	-109.02M 59.15%	-63.90M 41.38%
depreciation and amortization							94.40M -	96.40M 2.12%	93M 3.53%	105M 12.90%	104.80M 0.19%	105.70M 0.86%
deferred income tax
stock based compensation
change in working capital
accounts receivables
inventory
accounts payables
other working capital
other non cash items	-117M -	152.80M 230.60%	-224M 246.60%	139M 162.05%	58.40M 57.99%		-94.40M -	-96.40M 2.12%	-92.86M 3.67%	-105M 13.07%	-104.80M 0.19%	174.20M 266.22%	109.02M 37.42%	63.90M 41.38%
net cash provided by operating activities	117M -	-152.80M 230.60%	224M 246.60%	-139M 162.05%	-58.40M 57.99%	-66.90M 14.55%	-56.90M 14.95%	-187.80M 230.05%	462.20M 346.11%	-79.10M 117.11%	-75.90M 4.05%	211.40M 378.52%
investments in property plant and equipment
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites
debt repayment
common stock issued
common stock repurchased
dividends paid
other financing activites
net cash used provided by financing activities
effect of forex changes on cash
net change in cash	117M -	-152.80M 230.60%	224M 246.60%	-139M 162.05%	-58.40M 57.99%	-66.90M 14.55%	-56.90M 14.95%	-654.90M 1,050.97%	462.20M 170.58%	-387.18M 183.77%	-75.90M 80.40%	211.40M 378.52%
cash at beginning of period							524M -	467.10M 10.86%	-154.12M 133.00%	308.08M 299.90%	367.80M 19.38%	291.90M 20.64%
cash at end of period	117M -	-152.80M 230.60%	224M 246.60%	-139M 162.05%	-58.40M 57.99%	-66.90M 14.55%	467.10M 798.21%	-187.80M 140.21%	308.08M 264.05%	-79.10M 125.68%	291.90M 469.03%	503.30M 72.42%
operating cash flow	117M -	-152.80M 230.60%	224M 246.60%	-139M 162.05%	-58.40M 57.99%	-66.90M 14.55%	-56.90M 14.95%	-187.80M 230.05%	462.20M 346.11%	-79.10M 117.11%	-75.90M 4.05%	211.40M 378.52%
capital expenditure
free cash flow	117M -	-152.80M 230.60%	224M 246.60%	-139M 162.05%	-58.40M 57.99%	-66.90M 14.55%	-56.90M 14.95%	-187.80M 230.05%	462.20M 346.11%	-79.10M 117.11%	-75.90M 4.05%	211.40M 378.52%

BI

COM:BILCARE

Bilcare

Last Close

53.81

22/11 09:59

Market Cap

1.35B

Beta: -

Volume Today

10.98K

Avg: -

Preview